Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
34,309,263
-
Total 13F shares
-
9,462,229
-
Share change
-
+168,893
-
Total reported value
-
$56,207,308
-
Price per share
-
$5.94
-
Number of holders
-
25
-
Value change
-
+$983,452
-
Number of buys
-
11
-
Number of sells
-
13
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q1 2020
As of 31 Mar 2020,
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,462,229 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Avoro Capital Advisors LLC, Solas Capital Management, LLC, 683 Capital Management, LLC, Sonic Fund II, L.P., EVENTIDE ASSET MANAGEMENT, LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Cadence Capital Management LLC, OXFORD ASSET MANAGEMENT LLP, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
25
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.